Close

Vetter strengthens worldwide commitment to sustainable business practices

Related stories

hubXchange Announces Upcoming Series of Exclusive Roundtable Events in San Diego – February 2025

hubXchange, the premier platform for senior-level knowledge exchange in...

Aragen receives Platinum Medal from EcoVadis for its sustainability initiatives

Hyderabad: Aragen Life Sciences, a globally renowned Contract Research,...

Danish protein analysis to revolutionize the biopharma industry’s impurity control

The requirements for quality assurance of biologics are increasing....

Berry Global Healthcare to Showcase New Packaging Innovations at Pharmapack 2025

Berry Global Healthcare, a leader in innovative packaging solutions,...
  • Globally, Vetter is one of over 300 companies in the pharma and biotech industry that have signed the UN Global Compact
  • Membership drives expansion of ecologically and socially responsible supply chains and sustainable business processes in the biopharma industry
  • Internationally operating CDMO expands sustainability activities onto a global level

Ravensburg, March 8th, 2023 – Vetter has recently become a participant of the UN Global Compact Network (UN GC). The globally operating Contract Development and Manufacturing Organization (CDMO) is one of the pioneers in the industry regarding responsible, sustainable, and transparent business practices. To date, only 308 biopharmaceutical companies worldwide have signed the UN Global Compact. By joining, Vetter commits itself to aligning and documenting its corporate actions to the ten defined principles. Their focus is on the enforcement and implementation of human and employee rights, environmental protection, and the prevention of corruption.

Henryk Badack, Senior Vice President Technical Service and Internal Project Management is responsible for all global sustainability activities at Vetter. He explains: “We have already been pursuing a very ambitious sustainability strategy for years. By committing to the goals of the UN Global Compact, we are reaching the next level and are further expanding our initiatives to a global level.”

As a participant, Vetter gains access to the large network of companies and organizations that are committed to the same corporate goals. This includes much more than CO2 reduction. The initiative sees itself as an open forum to initiate change processes and share ideas and best practice concepts. In national networks, participants develop concrete approaches to solutions and thus contribute to the overarching vision of the UN Global Compact. Vetter will submit an annual progress report. The publicly viewable document (Communication of Progress, COP) serves as important evidence of transparency and accountability.

“As a family-owned business in the healthcare sector, we bear great responsibility,” says Henryk Badack. “And we believe in the power of cooperation. The UN Global Compact combines these two approaches very well and is also a strong commitment to shared values and goals across business sectors and national borders.”

With its own comprehensive initiatives, Vetter also simultaneously supports its customers and partners in their sustainable supply chain. Together, the companies achieve a responsible flow of goods and sustainable business processes in the biopharmaceutical industry.

Launched in 2000, the UN Global Compact is the largest corporate initiative on sustainable business worldwide. More than 15,000 companies and 3,000 non-profit organizations from over 160 countries have signed the initiative to date. Further information on the UN Global Compact Network: http://www.unglobalcompact.org

Company: Vetter Pharma-Fertigung GmbH & Co. KG


Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the pharmaceutical service provider is also present with its own sales locations in the Asia-Pacific markets of Japan, China, South Korea and Singapore. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of more than 6,300 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions, Vetter develops prefilled drug-delivery systems together with its customers to continuously improv

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories